Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS    Call Me Free
Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75) Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75) Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75)
Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75)
Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75) Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75)

Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75)

Product Details:

  • Usage Type Single-use, disposable
  • Features Thin strut, enhanced deliverability, radiopaque core, suitable for small vessels, superior conformability, low restenosis rate
  • Function Prevents arterial restenosis by controlled zotarolimus drug release
  • Instruments Type Interventional Cardiology Stent
  • Shelf Life 2 - 3 years (as per sterile packaging)
  • Measurement Range Stent Diameter: 2.75 mm; Lengths: 8-34 mm
  • Accuracy High procedural placement accuracy
  • Click to View more
X

Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75) Price And Quantity

  • 0.014" guidewire compatible, rapid exchange
  • Indicated on packaging
  • Balloon expandable
  • Conforms to CE, US FDA, ISO standards
  • Sterile, EO gas processed
  • Enhanced with platinum-iridium core for optimal visibility
  • For use in patients with de novo coronary artery lesions
  • 5 Fr (1.67 mm inner diameter)
  • Zotarolimus (BioLinx polymer matrix)

Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75) Product Specifications

  • 2 - 3 years (as per sterile packaging)
  • Thin strut, enhanced deliverability, radiopaque core, suitable for small vessels, superior conformability, low restenosis rate
  • Drug-Eluting Stent (DES) with zotarolimus elution
  • Single-use, disposable
  • New
  • Stent Diameter: 2.75 mm; Lengths: 8-34 mm
  • Prevents arterial restenosis by controlled zotarolimus drug release
  • Ultra-light (single-use catheter system)
  • Treatment of coronary artery stenosis (PCI procedures)
  • Manual Catheter-Delivered
  • Silent / Not Applicable
  • Yes (catheter-based)
  • Interventional Cardiology Stent
  • Not Required (manual operation)
  • High procedural placement accuracy
  • Yes (immediate deployment in cath lab)
  • Drug-Eluting Coronary Stent
  • Metallic with polymer coating
  • No
  • Stent diameter: 2.75 mm; Lengths: 8 mm, 12 mm, 15 mm, 18 mm, 22 mm, 26 mm, 30 mm, 34 mm (varies by option)
  • Store in original blister packaging at room temperature, avoid direct sunlight
  • Cobalt Alloy with BioLinx Polymer Coating
  • 0.014" guidewire compatible, rapid exchange
  • Indicated on packaging
  • Balloon expandable
  • Conforms to CE, US FDA, ISO standards
  • Sterile, EO gas processed
  • Enhanced with platinum-iridium core for optimal visibility
  • For use in patients with de novo coronary artery lesions
  • 5 Fr (1.67 mm inner diameter)
  • Zotarolimus (BioLinx polymer matrix)

Product Description

Brand Medtronic
Stent Diameter (mm) 2.75
Stent Length (mm) 15 & 18
CAT No RONYX27515W & RONYX27518W
Catheter Length 300 cm

Resolute Onyx is a drug-eluting stent (DES) that's different by design, optimised for complex PCI, and proven safe and effective in real-world, high bleeding risk patients on 1-month dual antiplatelet therapy (DAPT). Resolute Onyx drug-eluting stent (DES) offers flexibility, conformability, a 2.0-5.0 mm size matrix, and is indicated for high bleeding risk patients and labeled for one-month DAPT.



Advanced Drug-Eluting Technology

The Resolute Onyx DES employs a unique BioLinx polymer matrix to deliver zotarolimus with precision, reducing the risk of arterial restenosis. This advanced coating technology ensures sustained drug release directly at the lesion site, enhancing long-term patency.


Exceptional Deliverability and Visibility

Featuring a thin strut design with a platinum-iridium core, the Resolute Onyx stent is ultra-lightweight and highly radiopaque. These features support smooth navigation through coronary vessels and allow for exact positioning, even in complex procedures.


Versatile and Compatible System

This stent system is designed for ease of use, compatible with 0.014'' guidewires and requiring a minimum 5 Fr (1.67 mm) guide catheter. With a variety of length options (8-34 mm), it accommodates diverse lesion lengths to personalize patient care.

FAQ's of Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75):


Q: How is the Medtronic Resolute Onyx DES deployed during a PCI procedure?

A: The stent is manually delivered via a balloon-expandable, rapid-exchange catheter system. It is inserted through a compatible 5 Fr guide catheter over a 0.014'' guidewire and expanded at the lesion site during the procedure.

Q: What size options are available for the Resolute Onyx DES (2.75 mm diameter)?

A: The stent is available in lengths ranging from 8 mm to 34 mm, allowing clinicians to select the most appropriate length based on the characteristics of the target lesion.

Q: When should the Resolute Onyx DES be used?

A: This stent is indicated for patients with de novo coronary artery lesions requiring percutaneous coronary intervention (PCI). It delivers controlled zotarolimus release to reduce restenosis risk following angioplasty.

Q: Where should the Resolute Onyx DES be stored prior to use?

A: Store the stent in its original blister packaging at room temperature. Ensure it is kept away from direct sunlight and only opened immediately before use to maintain sterility.

Q: What are the main benefits of the Resolute Onyx DES?

A: Key advantages include enhanced deliverability, thin strut design for small vessel compatibility, high radiopacity for precise placement, and reduced restenosis rates due to controlled drug release.

Q: How does the stent maintain its sterilization and shelf life?

A: The stent is sterilized using EO gas and is single-use disposable. The expiration date is indicated on the packaging, with a typical shelf life of 2-3 years if stored properly.

Q: What steps are involved in using the Resolute Onyx DES during treatment?

A: The process involves preparing the lesion site, advancing the stent over a 0.014'' guidewire using a rapid-exchange delivery catheter, deploying it at the targeted lesion, and removing the delivery system following successful placement.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical Surgicals' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.